NAFDAC warns against fake asthma inhalers
NAFDAC has issued an urgent alert to healthcare providers and patients against falsified asthma inhalers detected in open markets, with enforcement teams deployed to confiscate fake batches.
The National Agency for Food and Drug Administration and Control (NAFDAC) issued an urgent alert warning healthcare providers and patients against falsified asthma inhalers detected in open markets. Regulatory enforcement teams were deployed across major distribution centers to confiscate fake batches.
The alert is a recognition of the growing threat of counterfeit drugs in Nigeria. Fake asthma inhalers pose a serious health risk, and NAFDAC’s swift action is commendable. The deployment of enforcement teams across major distribution centres suggests that the agency is taking the threat seriously.
This echoes the 2020 alert on counterfeit drugs, which also prompted swift action by NAFDAC. The mechanism then was different, but the result was the same: a focus on protecting public health.
The winners: patients, who are protected from dangerous counterfeit drugs; and NAFDAC, which has acted swiftly. The losers: the counterfeiters, who face enforcement action; and the Nigerian public, who must remain vigilant.
Bottom Line: NAFDAC has warned against fake asthma inhalers. Enforcement teams are deployed. The question is whether the alert will stop the spread of counterfeit drugs.